SEC Form 4 · accession 0001078782-15-002095
AXIM BIOTECHNOLOGIES, INC. · AXIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lekhram Changoer
Director · 10% Owner
Period of report
Apr 23, 2015
Accepted (ET)
Dec 30, 2015 · 3:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001514946
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Preferred StockF1 | Apr 23, 2015 | A | 1,000,000 | $0.00 | A | 1,500,000 | I | See footnote |
| Common Stock | Dec 18, 2015 | A | 25,000 | $0.00 | A | 25,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F11,000,000 shares are held by Treo Holdings LLC which reporting person is a member. 500,000 shares are held by Sanammad Foundation which reporting person is a member.